Literature DB >> 3924253

Intolerance of bromocriptine: is metergoline a satisfactory alternative?

I F Casson, B A Walker, L J Hipkin, P E Belchetz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924253      PMCID: PMC1415939          DOI: 10.1136/bmj.290.6484.1783

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients.

Authors:  P G Chiodini; A Liuzzi; E E Muller; L Botalla; G Cremascoli; G Oppizzi; G Verde; F Silvestrini
Journal:  J Clin Endocrinol Metab       Date:  1976-08       Impact factor: 5.958

2.  Prolactin suppression by serotonin antagonists in man: further evidence for serotoninergic control of prolactin secretion.

Authors:  C Ferrari; R Caldara; M Romussi; P Rampini; P Telloli; S Zaatar; G Curtarelli
Journal:  Neuroendocrinology       Date:  1978       Impact factor: 4.914

3.  Metergoline and cyproheptadine suppress prolactin release by a non-5-hydroxytryptaminergic, non-dopaminergic mechanism.

Authors:  G M Besser; G Delitala; A Grossman; T Yeo
Journal:  Br J Pharmacol       Date:  1980-09       Impact factor: 8.739

4.  Effect of an antiserotoninergic drug, metergoline, on the ACTH and cortisol response to insulin hypoglycemia and lysine-vasopressin in man.

Authors:  F Cavagnini; U Raggi; P Micossi; A Di Landro; C Invitti
Journal:  J Clin Endocrinol Metab       Date:  1976-08       Impact factor: 5.958

  4 in total
  1 in total

1.  Clinical evaluation of lysuride in the management of hyperprolactinaemia.

Authors:  P M Bouloux; G M Besser; A Grossman; P J Moult
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.